Private equity firms play ‘pass the Parexel’ with $8.5bn handover deal
pharmaphorum
JULY 5, 2021
billion to claim ownership of the contract research organisation. Macdonald said the new partnership with Goldman Sachs and EQT will help Parexel meet “customers’ needs for innovation in such areas as real world evidence, decentralised clinical trials, biostatistics and data management – and in key regions such as Asia/Pacific.”
64 
Let's personalize your content